Tagged with Franc

Quintiles France As Quintiles is present in all major pharmaceutical markets worldwide, what’s the relevance of the French affiliate and what role it plays inside such a globalized organization? France is important to Quintiles not only because it is in itself a major pharmaceutical market itself but also because many of Quintiles’…

Daiichi Sankyo France When we met your Italian colleague, he noted that they had tripled their turnover in a five year period. You haven’t done badly yourself in the relatively short period of time you’ve been present in the Market. Is this a European-wide phenomenon for Daiichi Sankyo or is there something special…

Janssen-Cilag France Janssen-Cilag is involved in not only selling its products in France but research and production as well. As France is a leading subsidiary, can you speak to the importance of the market not only in Europe but overall for the group? We are very proud of being the largest Johnson…

Actavis France Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an acquisition of Torlan Laboratoires. As the last actor to enter the market, what was the motivation to move into the…

Eisai France Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is Eisai in France going to bridge the gap between this blockbuster and the other developments that are coming down the pipeline? In regard…

Boehringer Ingelheim France There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September you moved into these new facilities here at Paris Biopark. What does this express about the moves Boehringer Ingelheim is taking in France and…

Sanofi Aventis France As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health care industry since it seems that the industrial aspects have been overlooked in recent years. I would also like to…

Roche France Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market for the group overall? The affiliate in France is one of the largest European affiliate and historically we have held a strong presence through…

Ipsen France As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and the purpose of the group today? The pharmaceutical industry has been present in France for many years and is one of the country’s traditional…

AstraZeneca France You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a rising generics market in France and increased regulations for market authorization. How has the business changed for AstraZeneca in this…

GSK France France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like? I have spent half of my career abroad but always having worked for a French pharmaceutical company whether it was Fournier or sanofi-aventis. Of…

France Biotech France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this? In fact, there were some delays in consciousness of the biotech trend. Compared to other countries, it took more time…